Charting a Bold Path for 2025
Exciting times are ahead for Camber Pharmaceuticals in 2025!
We are on track to launch up to 55 new generic medications, including several Day-One products, specialty drugs, and over-the-counter (OTC) medications. Additionally, we are continuing our investment in portfolio expansion, critical infrastructure, and associate development to create an even more significant impact.
To learn more, please watch this short message from Camber’s management team!
Recent articles
- Camber Launches Temozolomide Capsules, USP
- Camber Launches Eltrombopag Tablets & Oral Suspension
- Camber Launches Eslicarbazepine Acetate Tablets
- Camber Launches Phenylephrine Hydrochloride Injection, USP
- Camber Launches Chlorzoxazone Tablets, USP
- Camber Launches 13 New Generic Products in Q1 2025, Sets Ambitious Pace for the Year